studied 32 PCNSL specimens and found that PD-1 expression in tumor-infiltrating lymphocytes was 58% and PD-L1 expression in tumor cells was 37%, while patients with high PD-1 expression had significantly lower OS than patients with low PD-1 expression (71). The gene discussed is PDCD1; the disease is neoplasm.